- Home
- SBCF vs CPRX Comparison
SBCF vs CPRX Comparison
Compare SBCF & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- CPRX
- Stock Information
- Founded
- SBCF 1926
- CPRX 2002
- Country
- SBCF United States
- CPRX United States
- Employees
- SBCF N/A
- CPRX N/A
- Industry
- SBCF Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SBCF Finance
- CPRX Health Care
- Exchange
- SBCF Nasdaq
- CPRX Nasdaq
- Market Cap
- SBCF 2.5B
- CPRX 2.5B
- IPO Year
- SBCF N/A
- CPRX 2006
- Fundamental
- Price
- SBCF $28.57
- CPRX $23.09
- Analyst Decision
- SBCF Buy
- CPRX Strong Buy
- Analyst Count
- SBCF 4
- CPRX 7
- Target Price
- SBCF $29.00
- CPRX $32.86
- AVG Volume (30 Days)
- SBCF 376.1K
- CPRX 1.5M
- Earning Date
- SBCF 01-27-2025
- CPRX 02-26-2025
- Dividend Yield
- SBCF 2.59%
- CPRX N/A
- EPS Growth
- SBCF 15.45
- CPRX 114.68
- EPS
- SBCF 1.42
- CPRX 1.18
- Revenue
- SBCF $499,141,000.00
- CPRX $460,482,000.00
- Revenue This Year
- SBCF N/A
- CPRX $23.85
- Revenue Next Year
- SBCF $7.91
- CPRX $16.76
- P/E Ratio
- SBCF $19.57
- CPRX $19.59
- Revenue Growth
- SBCF N/A
- CPRX 32.17
- 52 Week Low
- SBCF $21.90
- CPRX $13.12
- 52 Week High
- SBCF $31.68
- CPRX $24.64
- Technical
- Relative Strength Index (RSI)
- SBCF 59.84
- CPRX 55.61
- Support Level
- SBCF $27.43
- CPRX $21.69
- Resistance Level
- SBCF $28.71
- CPRX $24.64
- Average True Range (ATR)
- SBCF 0.75
- CPRX 0.96
- MACD
- SBCF 0.24
- CPRX 0.01
- Stochastic Oscillator
- SBCF 85.71
- CPRX 47.46
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.